Hospital
Tri-County Memorial Hospital, INC.
Tri-County Memorial Hospital, INC. was paid $4.13M by Medicaid between Jan 2018 and Dec 2024, across 93 billing codes. Its largest line is 99283, emergency room visit (moderate) — 20% of everything it billed.
33Billing provider infoTRI-COUNTY MEMORIAL HOSPITAL, INC.
WHITEHALL, WI 54773
WHITEHALL, WI 54773
33aNPI1124063573assigned 06/19/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$4.13M
24GClaims94,012
24DCodes billed93
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Wisconsin
Rank by total paid#29 of 60
Median peer was paid$2.90M
This provider vs. median1.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 10,171 | $374K | |
| 2019 | 8,260 | $302K | |
| 2020 | 11,073 | $458K | |
| 2021 | 15,016 | $619K | |
| 2022 | 14,659 | $827K | |
| 2023 | 18,237 | $855K | |
| 2024incomplete | 16,596 | $698K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 20% | 4,209 | 3,335 | $832K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 18% | 3,423 | 2,749 | $759K |
| 96361 | Intravenous infusion, hydration; each additional hour | 15% | 1,378 | 921 | $610K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10% | 2,167 | 1,861 | $425K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 10% | 4,446 | 3,760 | $420K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 4.1% | 2,057 | 1,548 | $169K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.0% | 1,309 | 1,111 | $84K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 2,096 | 1,757 | $74K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1.7% | 1,789 | 1,214 | $72K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.4% | 326 | 279 | $56K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.3% | 751 | 637 | $53K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 2,257 | 1,540 | $45K |
81 more codes
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.1% | 563 | $44K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 390 | $40K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,140 | $26K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 106 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 493 | $23K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,061 | $22K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | <1% | 502 | $21K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 680 | $20K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 1,337 | $19K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,063 | $19K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,525 | $19K |
| 80051 | <1% | 3,773 | $19K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 808 | $16K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 49 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,072 | $15K |
| 82565 | <1% | 4,750 | $15K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 57 | $13K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,762 | $12K |
| 80061 | Lipid panel | <1% | 948 | $11K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,394 | $10K |
| 84460 | <1% | 2,734 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 959 | $8K |
| 82947 | <1% | 3,050 | $8K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 458 | $8K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,414 | $6K |
| 84450 | <1% | 1,808 | $6K | |
| 81001 | <1% | 2,200 | $6K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 16 | $6K |
| 71045 | Radiologic examination, chest; single view | <1% | 493 | $5K |
| 84075 | <1% | 1,816 | $5K | |
| 84520 | <1% | 2,668 | $5K | |
| 82247 | <1% | 2,025 | $5K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 83 | $5K |
| 85027 | <1% | 908 | $5K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 142 | $5K |
| 87081 | <1% | 419 | $4K | |
| 83690 | <1% | 680 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 246 | $3K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 534 | $2K |
| A0380 | Bls mileage (per mile) | <1% | 159 | $2K |
| 81025 | <1% | 243 | $2K | |
| 82040 | <1% | 575 | $2K | |
| 84484 | <1% | 447 | $2K | |
| 85610 | <1% | 645 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 565 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 372 | $1K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 89 | $1K |
| 83605 | <1% | 310 | $1K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 31 | $1K |
| 90686 | <1% | 50 | $991.41 | |
| 81003 | <1% | 481 | $939.14 | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 240 | $866.79 |
| 84132 | <1% | 186 | $683.18 | |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 97 | $489.47 |
| 82310 | <1% | 168 | $426.78 | |
| 90656 | <1% | 19 | $396.04 | |
| 83735 | <1% | 113 | $347.92 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 14 | $305.90 |
| 84145 | <1% | 41 | $304.99 | |
| 3008F | <1% | 29 | $260.00 | |
| 87077 | <1% | 69 | $248.40 | |
| G0378 | Hospital observation service, per hour | <1% | 25 | $226.25 |
| 86140 | <1% | 47 | $187.05 | |
| 80053 | Comprehensive metabolic panel | <1% | 46 | $185.47 |
| 82728 | <1% | 17 | $126.72 | |
| 82962 | <1% | 63 | $114.80 | |
| 82077 | <1% | 16 | $110.56 | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 833 | $99.68 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,999 | $80.70 |
| 87186 | <1% | 18 | $71.52 | |
| A9270 | Non-covered item or service | <1% | 5,447 | $56.23 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 109 | $30.19 |
| 85018 | <1% | 14 | $24.50 | |
| 87040 | <1% | 27 | $21.32 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 52 | $10.49 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 494 | $9.66 |
| J3490 | Unclassified drugs | <1% | 104 | $7.69 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 208 | $6.34 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 142 | $2.44 |
| A0425 | Ground mileage, per statute mile | 0% | 33 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSCHLEICH, ROXANE (CFO, REGIONAL)
| Provider | Location | Paid |
|---|---|---|
| Tri-County Memorial Hospital, INC. | Whitehall, WI | $200K |
| Tri-County Memorial Hospital, INC. | Blair, WI | $7K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.